Serotype distribution of Streptococcus pneumoniae in children with invasive diseases in Turkey: 2008–2014

References

• World Health Organization. Pneumococcal disease [cited 2015 Feb 20]. n.d. Available from: http://www.who.int/ith/diseases/pneumococcal/en/
   Google Scholar
• Isaacman DJ, McIntosh ED, Reinert RR. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines. Int J Infect Dis 2010; 14:e197-209; PMID:19700359; http://dx.doi.org/10.1016/j.ijid.2009.05.010
   PubMed Web of Science ®Google Scholar
• Pletz MW, Maus U, Krug N, Welte T, Lode H. Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species. Int J Antimicrob Agents 2008; 32:199-206; PMID:18378430; http://dx.doi.org/10.1016/j.ijantimicag.2008.01.021
   PubMed Web of Science ®Google Scholar
• Feikin DR, Klugman KP. Historical changes in pneumococcal serogroup distribution: implications for the era of pneumococcal conjugate vaccines. Clin Infect Dis 2002; 35:547-55; PMID:12173128; http://dx.doi.org/10.1086/341896
   PubMed Web of Science ®Google Scholar
• Weinberger DM, Malley R, Lipsitch M. Serotype replacement in disease after pneumococcal vaccination. Lancet 2011; 378:1962-73; PMID:21492929; http://dx.doi.org/10.1016/S0140-6736(10)62225-8
   PubMed Web of Science ®Google Scholar
• World Health Organization. Pneumococcal conjugate vaccine for childhood immunization – WHO position paper. Weekly epidemiological report. Weekly Epidemiological Record 2007; 82:93-104; PMID:17380597
   PubMedGoogle Scholar
• Weil-Olivier C, van der Linden M, de Schutter I, Dagan R, Mantovani L. Prevention of pneumococcal diseases in the post-seven valent vaccine era: a European perspective. BMC Infect Dis 2012; 12:207; PMID:22954038; http://dx.doi.org/10.1186/1471-2334-12-207
   PubMed Web of Science ®Google Scholar
• Johnson HL, Deloria-Knoll M, Levine OS, Stoszek SK, Freimanis Hance L, Reithinger R, Muenz LR, O'Brien KL. Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: The pneumococcal global serotype project. PLoS Med 2010; 7:e1000348; PMID:20957191; http://dx.doi.org/10.1371/journal.pmed.1000348
   PubMed Web of Science ®Google Scholar
• Ceyhan M, Ozsurekci Y, Gürler N, Ozkan S, Sensoy G, Belet N, Hacimustafaoglu M, Celebi S, Keser M, Dinleyici EC, et al. Serotype distribution of Streptococcus pneumoniae causing parapneumonic empyema in Turkey. Clin Vaccine Immunol 2013; 20:972-6; PMID:23637041; http://dx.doi.org/10.1128/CVI.00765-12
   PubMed Web of Science ®Google Scholar
• Ceyhan M, Gurler N, Yaman A, Ozturk C, Oksuz L, Ozkan S, Keser M, Salman N, Alhan E, Esel D, et al. Serotypes of Streptococcus pneumoniae isolates from children with invasive pneumococcal disease in Turkey: baseline evaluation of the introduction of the pneumococcal conjugate vaccine nationwide. Clin Vaccine Immunol 2011; 18:1028-30; PMID:21508171; http://dx.doi.org/10.1128/CVI.00526-10
   PubMed Web of Science ®Google Scholar
• Feikin DR, Klugman KP, Facklam RR, Zell ER, Schuchat A, Whitney CG. Increased prevalence of pediatric pneumococcal serotypes in elderly adults. Clin Infect Dis 2005; 41:481-7; PMID:16028155; http://dx.doi.org/10.1086/432015
   PubMed Web of Science ®Google Scholar
• Imöhl M, Reinert RR, van der Linden M. Regional differences in serotype distribution, pneumococcal vaccine coverage, and antimicrobial resistance of invasive pneumococcal disease among German federal states. Int J Med Microbiol 2010; 300:237-47; PMID:19604721; http://dx.doi.org/10.1016/j.ijmm.2009.05.005
   PubMed Web of Science ®Google Scholar
• Jacobs MR, Good CE, Bajaksouzian S, Windau AR. Emergence of Streptococcus pneumoniae serotypes19A, 6C, and 22F and serogroup 15 in Cleveland, Ohio, in relation to introduction of the proteinconjugated pneumococcal vaccine. Clin Infect Dis 2008; 47:1388-95; PMID:18959493; http://dx.doi.org/10.1086/592972
   PubMed Web of Science ®Google Scholar
• Regev-Yochay G, Paran Y, Bishara J, Oren I, Chowers M, Tziba Y, Istomin V, Weinberg M, Miron D, Temper V, et al. Early impact of PCV7/PCV13 sequential introduction to the national pediatric immunization plan, on adult invasive pneumococcal disease: A nationwide surveillance study. Vaccine 2015; 33:1135-42; PMID:25613717; http://dx.doi.org/10.1016/j.vaccine.2015.01.030
   PubMed Web of Science ®Google Scholar
• Lepoutre A, Varan E, Georges S, Dorleans F, Janoir C, Gutmann L, Levy-Bruhl D, Microbiologists of Epibac; ORP Networks. Impact of the pneumococcal conjugate vaccines on invasive pneumococcal disease in France, 2001-2012. Vaccine 2015; 33:359-66; PMID:25448105; http://dx.doi.org/10.1016/j.vaccine.2014.11.011
   PubMed Web of Science ®Google Scholar
• Ceyhan M, Yildirim I, Sheppard CL, George RC. Pneumococcal serotypes causing pediatric meningitis in Turkey: application of a new technology in the investigation of cases negative by conventional culture. Eur J Clin Microbiol Infect Dis 2010; 29:289-93; PMID:20087750; http://dx.doi.org/10.1007/s10096-009-0853-y
   PubMed Web of Science ®Google Scholar
• Skoczynska A, Kuch A, Sadowy E, Wasko I, Markowska M, Ronkiewicz P, Matynia B, Bojarska A, Wasiak K, Golebiewska A, et al. Recent trends in epidemiology of invasive pneumococcal disease in Poland. Eur J Clin Microbiol Infect Dis 2015; 34:779-87; PMID:25475124; http://dx.doi.org/10.1007/s10096-014-2283-8
   PubMed Web of Science ®Google Scholar
• Kyaw MH, Lynfield R, Schaffner W, Craig AS, Hadler J, Reingold A, Thomas AR, Harrison LH, Bennet NM, Farley MM, et al. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med 2006; 354:1455-63; PMID:16598044; http://dx.doi.org/10.1056/NEJMoa051642
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction-eight states, 1998-2005. JAMA 2008; 299:1253-5; http://dx.doi.org/10.1001/jama.299.11.1253
   Web of Science ®Google Scholar
• Ben-Shimol S, Greenberg D, Given-Lavi N, Schlesinger Y, Somekh E, Aurier S, Miron D, Dagan R. Early impact of sequential introduction of 7-valent and 13-valent pneumococcal conjugate vaccine on IPD in Israeli children. Vaccine 2014; 32:3452-9; PMID:24690148; http://dx.doi.org/10.1016/j.vaccine.2014.03.065
   PubMed Web of Science ®Google Scholar
• Dagan R. Serotype replacement in perspective. Vaccine 2009; 27(Suppl 3):C22-4; PMID:19545935; http://dx.doi.org/10.1016/j.vaccine.2009.06.004
   PubMedGoogle Scholar
• Feikin DR, Kagucia EW, Loo JD, Link-Gelles R, Puhan MA, Cherion T, Levine OS, Whitney CG, O'Brien KL, Moore MR; Serotype Replacement Study Group. Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites. PLoS Med 2013; 10:e1001517; PMID:24086113; http://dx.doi.org/10.1371/journal.pmed.1001517
   PubMed Web of Science ®Google Scholar
• Ben-Shimol S, Greenberg D, Given-Lavi N, Elias N, Glikman D, Rubinstein U, Dagan R. Israeli bacteremia and meningitis active surveillance group. Rapid reduction in invasive pneumococcal disease after introduction of PCV7 into the national immunization plan in Israel. Vaccine 2012; 30:6600-7; PMID:22939907; http://dx.doi.org/10.1016/j.vaccine.2012.08.012
   PubMed Web of Science ®Google Scholar
• Navarro Torne A, Dras JG, Quinten C, Hruba F, Busana MC, Lopalca LP, Gauci AJ, Pastore-Celentano L. ECDC country experts for pneumococcal disease. European ehanced surveillance of invasive pneumococcal disease in 2010: data from 26 European countries in the post-heptavalent conjugate vaccine era. Vaccine 2014; 32:3644-50; PMID:24795228; http://dx.doi.org/10.1016/j.vaccine.2014.04.066
   PubMed Web of Science ®Google Scholar
• Phanhsamart W, Srifeung S, Chatsuwan T, Nunthapisud P, Treerauthaweeraphong V, Rungnobhakhun P, Sricharoenchai S, Chokephaibulkit K. Changing trends in serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae causing invasive diseases in central Thailand, 2009-2012. Hum Vaccin Immunother 2014; 10:1866-73; PMID:25424794; http://dx.doi.org/10.4161/hv.28675
   PubMed Web of Science ®Google Scholar
• Ceyhan M, Gürler N, Ozsurekci Y, Keser M, Aycan AE, Gurbuz V, Salman N, Camcioglu Y, Dinleyici EC, Ozkan S, et al. Meningitis caused by Neisseria meningitidis, haemophilus influenzae type B and streptococcus pneumoniae during 2005-2012 in Turkey: A multicenter prospective surveillance study. Hum Vaccin Immunother 2014; 10:2706-12; PMID:25483487; http://dx.doi.org/10.4161/hv.29678
   PubMed Web of Science ®Google Scholar
• Yalcin I, Gurler N, Alhan E, Yaman A, Turgut M, Celik U, Akcakaya N, Camcioglu Y, Diren S, Yildirim B. Serotype distribution and antibiotic susceptibility of invasive Streptococcus pneumoniae disease isolates from children in Turkey, 2001-2004. Eur J Pediatr 2006; 165:654-7; PMID:16602003; http://dx.doi.org/10.1007/s00431-006-0128-x
   PubMed Web of Science ®Google Scholar
• Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard-Eleventh Edition; 9-10 [cited 2016 Jan 31]. Wayne, PA: Clinical and Laboratory Standards Institute; 2012. Available from: http://www.antimicrobianos.com.ar/ATB/wp-content/uploads/2012/11/01-CLSI-M02-A11-2012.pdf
   Google Scholar